Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003;92:e78
doi: 10.1161/01.RES.0000072823.84611.9B
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rupp, J.
Right arrow Articles by Maass, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rupp, J.
Right arrow Articles by Maass, M.
(Circulation Research. 2003;92:e78.)
© 2003 American Heart Association, Inc.


Letter to the Editor

Egr-1, a Major Link Between Infection and Atherosclerosis?

Jan Rupp, Matthias Maass

Institute of Medical Microbiology, and Hygiene, University of Lübeck, Lübeck, Germany, maass@hygiene.mu-luebeck.de


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

The study of Bea et al,1 recently published in Circulation Research, investigated the role of Chlamydia pneumoniae infection in mouse macrophages on the induction of tissue factor (TF) via activation of Egr-1. Chlamydial infection of RAW mouse macrophages clearly resulted in enhanced Egr-1 protein expression and a subsequent time-dependent increase in TF mRNA expression and procoagulatory activity. We can confirm the postinfectious Egr-1 induction described by Bea et al. In addition, we can expand their findings and demonstrate a broader regulatory influence of Egr-1 on proatherosclerotic factors in C pneumoniae–infected mononuclear cells that is not limited to prothrombotic molecules and not restricted to mouse macrophages.

We performed similar experiments as Bea et al1 but used blood monocytes from healthy blood donors and found that infection with the cardiovascular chlamydial strain CV-6 (isolated from a 68-year-old man with coronary restenosis2) significantly induced Egr-1 mRNA expression (15.8-fold±4.7, n=5; P<0.01; RT-PCR, LightCycler, Roche Molecular Biochemicals) after 1 hour. This is in line with the results of Bea et al, who observed maximum Egr-1 protein levels in the nuclei of infected RAW cells at 1 to 2 hours after infection. In contrast to Bea et al who focused on TF expression in mouse macrophages, we were interested whether Egr-1 is involved in the regulation of C pneumoniae–induced expression of the vascular endothelial growth factor (VEGF), which has been recently incriminated to promote atherosclerotic lesion formation and thus might also link infection and atherosclerosis.3 Enhanced VEGF immunoreactivity . . . [Full Text of this Article]